Drug Trial Radar · NCT00430118
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Last checked: Nov 19, 2026Latest source record: May 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,559
Actual
Start
Jul 2000
Primary completion
Jan 2012
Study completion Jan 2012
Sponsor
- Lead sponsor
- University Hospital Schleswig-HolsteinAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 1, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating young patients with acute lymphoblastic leukemia. PURPOSE: Thisphase III trial is studying several different combination chemotherapy regimens to compare how well they work in treating young patients with acute lymphoblastic leukemia.
Conditions
- Leukemia
Interventions
asparaginaseDrug
cyclophosphamideDrug
cytarabineDrug
daunorubicin hydrochlorideDrug
dexamethasoneDrug
doxorubicin hydrochlorideDrug
etoposideDrug
ifosfamideDrug
mercaptopurineDrug
methotrexateDrug
prednisoneDrug
thioguanineDrug
vincristine sulfateDrug
vindesineDrug
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of dexamethasone vs prednisone during the induction phaseTime frame: End of Trial
- Event-free survival (EFS) and overall survival after initial remission in intermediate-risk and high-risk patientsTime frame: End of Trial
- Safety and efficacy of treatment reduction during reintensification in standard-risk patientsTime frame: End of Trial
- EFS after second delayed reintensification in intermediate-risk patientsTime frame: End of Trial
- Outcome after extended reintensification therapy in high-risk patientsTime frame: End of Trial
Locations
76 sites in 3 countries. Site status is shown where the registry gives one.
Krankenhaus Dornbirn
Dornbirn, Austria
Landeskrankenhaus Feldkirch
Feldkirch-Tisis, Austria
Universitaet Kinderklinik
Graz, Austria
Innsbruck Universitaetsklinik
Innsbruck, Austria
Landeskrankenhaus Klagenfurt
Klagenfurt, Austria
LKH Leoben
Leoben, Austria
A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung
Linz, Austria
Landes-Kinderkrankenhaus
Linz, Austria
St. Johanns-Spital
Salzburg, Austria
St. Anna Children's Hospital
Vienna, Austria
Kinderklinik - Universitaetsklinikum Aachen
Aachen, Germany
Klinikum Augsburg
Augsburg, Germany
Caritas-Krankenhaus Bad Mergentheim
Bad Mergentheim, Germany
Klinikum Bayreuth
Bayreuth, Germany
Helios Klinikum Berlin
Berlin, Germany
Charite University Hospital - Campus Virchow Klinikum
Berlin, Germany
Kinderklinik der Universitaet Bonn
Bonn, Germany
Staedtisches Klinikum - Howedestrase
Braunschweig, Germany
Klinikum Chemnitz gGmbH
Chemnitz, Germany
Klinikum Coburg
Coburg, Germany
Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl
Cologne, Germany
Children's Hospital
Cologne, Germany
Carl - Thiem - Klinkum Cottbus
Cottbus, Germany
Vestische Kinderklinik Universitaetsklinik Witten/Herdecke
Datteln, Germany
Klinikum Lippe - Detmold
Detmold, Germany
Klinikum Dortmund
Dortmund, Germany
Universitatsklinikum Carl Gustav Carus
Dresden, Germany
Klinikum Duisburg
Duisburg, Germany
Helios Klinikum Erfurt
Erfurt, Germany
Universitaets - Kinderklinik
Erlangen, Germany
Universitaetsklinikum Essen
Essen, Germany
Klinikum der J.W. Goethe Universitaet
Frankfurt, Germany
Universitaetskinderklinik - Universitaetsklinikum Freiburg
Freiburg im Breisgau, Germany
Kinderklinik
Giessen, Germany
Universitaetsklinikum Goettingen
Göttingen, Germany
Universitaetsklinikum Halle
Halle, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Universitaets-Kinderklinik Heidelberg
Heidelberg, Germany
SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
Heilbronn, Germany
Gemeinschaftskrankenhaus
Herdecke, Germany
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.